These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 6138301)
21. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects. Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791 [TBL] [Abstract][Full Text] [Related]
22. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. Misawa M; Kanai Y Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697 [TBL] [Abstract][Full Text] [Related]
23. Evidence for histamine and 5-hydroxytryptamine like effects of MK-212 on guinea pig ileum, taenia coli and rat fundus strip. Patel UP; Verma SC Indian J Physiol Pharmacol; 1981; 25(4):379-84. PubMed ID: 6122646 [TBL] [Abstract][Full Text] [Related]
24. Oxatomide: in vivo assessment of antagonistic activity, and effects on histamine release and enzymatic histamine degradation in skin. Gatti S; Coutts A; Francis D; Greaves MW Br J Dermatol; 1980 Dec; 103(6):671-7. PubMed ID: 6161634 [TBL] [Abstract][Full Text] [Related]
25. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part. Kaku T; Miyata T; Uruno T; Sako I; Kinoshita A Arzneimittelforschung; 1975 Apr; 25(4):539-47. PubMed ID: 239732 [TBL] [Abstract][Full Text] [Related]
26. Effects of SK&F 93944 (Temelastine), a potent histamine H1-receptor antagonist in pharmacologic and antigen-induced bronchoconstriction. Malo PE; Muccitelli R; Tucker SS; Wasserman MA Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):461-8. PubMed ID: 2875234 [TBL] [Abstract][Full Text] [Related]
27. [Azulenes and bradykinin]. Jelicić-Hadzović J; Stern P Arzneimittelforschung; 1972 Jul; 22(7):1210-1. PubMed ID: 4404344 [No Abstract] [Full Text] [Related]
28. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid. Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974 [TBL] [Abstract][Full Text] [Related]
30. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats. Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750 [TBL] [Abstract][Full Text] [Related]
31. [Effect of tremulacin on actions of SRS-A and histamine]. Yang DX; He KQ; Cheng GF Yao Xue Xue Bao; 1995; 30(4):254-7. PubMed ID: 7544944 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices]. Ohmori K; Ishii H; Shuto K; Nakamizo N Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585 [TBL] [Abstract][Full Text] [Related]
33. General pharmacological properties of the new vasodilator flosequinan. Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141 [TBL] [Abstract][Full Text] [Related]
34. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
35. [Antiallergic effects of a novel compound, SWR-00151]. Tanaka Y; Masai E; Yashima T; Furukawa M Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349 [TBL] [Abstract][Full Text] [Related]
37. New pharmacological aspects on the antiasthmatic activity of tiaramide-HCl. Folco GC; Omini C; Viganò T; Nicosia S; Lombroso M; Brunelli G; Rossoni G; Niada R; Berti F Arzneimittelforschung; 1982; 32(9):1092-5. PubMed ID: 6890832 [TBL] [Abstract][Full Text] [Related]
38. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline. Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463 [TBL] [Abstract][Full Text] [Related]
39. Effects of calcium and EDTA on rat skin capillary permeability and on its response to histamine, serotonin and bradykinin. Busch L; Tessler J; Bazerque PM Acta Physiol Pharmacol Latinoam; 1989; 39(3):227-34. PubMed ID: 2517461 [TBL] [Abstract][Full Text] [Related]
40. Biologically active substances in oak gall extracts. Part 11. The antihistamine-like activity of a substance (KC-18) isolated from oak gall extracts. Chu D; Kovacs BA Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):155-64. PubMed ID: 239649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]